We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Risk Factors for Cardiovascular and Metabolic Disease: Integrating Traditional and Novel Paradigms
AI summary Read the abstract
This review integrates traditional cardiovascular risk factors with emerging environmental risk factors including microplastics, air pollution, and endocrine disruptors, arguing that a significant proportion of cardiovascular events occur in individuals considered low-risk by conventional models alone.
ABSTRACT Cardiovascular and metabolic diseases (CVMD), encompassing atherosclerotic cardiovascular disease (ASCVD), heart failure, obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction‐associated steatotic liver disease (MASLD), remain the leading global cause of morbidity and mortality. Although traditional risk factors form the cornerstone of risk assessment, a significant proportion of events occur in individuals deemed low or intermediate risk by conventional models. This underscores the critical role of novel risk factors in CVMD. This review synthesizes current knowledge on both established and emerging risk factors for CVMD. We detail the pathophysiology, clinical significance, and interplay of traditional factors (dyslipidemia, hypertension, hyperuricemia, hyperhomocysteinemia, smoking, obesity, physical inactivity, unhealthy diet, and family history) and explore the growing evidence for novel risk factors, including inflammatory biomarker, lipid‐related factor, adipokines, lipid metabolite, air pollution, noise pollution, microplastics, heavy metals, and psychological factor. We discuss the integration of these factors into refined risk prediction models and their implications for personalized prevention and therapeutic strategies. Future research directions focusing on causality, mechanistic insights, and targeted interventions for novel risk markers are highlighted.
More Papers Like This
Relationship between microplastics and cardiovascular risk factors
AI summary Read the abstract
This review examines the emerging evidence linking microplastic exposure to cardiovascular risk factors, including endothelial dysfunction, oxidative stress, and inflammation, which are early indicators of heart disease. The authors conclude that microplastics represent a newly recognized environmental cardiovascular risk factor warranting further clinical research.
Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor
AI summary Read the abstract
Researchers reviewed mounting experimental and early clinical evidence that microplastics and nanoplastics cross epithelial barriers, accumulate in arterial plaques, cardiac tissue, and thrombi, and trigger oxidative stress and coagulation dysregulation, framing these particles as an emerging cardiovascular risk factor that warrants integration into disease prevention frameworks.
Contaminación medioambiental y salud cardiovascular. Retos y nuevas perspectivas
AI summary Read the abstract
This review examined the relationship between environmental pollution and cardiovascular disease, exploring the concept of the exposome. Researchers highlighted evidence that various environmental factors including air pollution, water contamination, and emerging pollutants like microplastics may contribute to cardiovascular disease development through arteriosclerotic pathways.
Riesgo cardiovascular femenino
AI summary Read the abstract
This review synthesizes evidence on clinical, hormonal, and environmental factors — including hormonal aging, microplastics, and environmental exposures — that influence cardiovascular disease risk in women, proposing integrated preventive strategies with a gender perspective.
02 | Micro- and Nanoplastics: a New Unconventional Risk Factor for Cardiovascular Health
AI summary Read the abstract
Researchers reviewed growing clinical and experimental evidence that micro- and nanoplastics can act as non-conventional cardiovascular risk factors, with MNPs detected directly within atherosclerotic plaques where their presence correlates with enhanced inflammatory activity, plaque instability, and worse cardiovascular outcomes—suggesting MNPs amplify established cardiometabolic risks through oxidative stress and endothelial dysfunction.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.